Description

9H-Imidazo[1,2-A]Purin-9-One, 3,5-Diacetyl-6,7-Bis(Acetyloxy)-3,5,6,7-Tetrahydro- is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel nucleoside analogs and purine derivatives with potential therapeutic activity. It is primarily sought by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions engaged in developing new active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: A key building block in the multi-step synthesis of novel purine-based drug candidates targeting various diseases.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to explore new chemical entities with potential antiviral, anticancer, or anti-inflammatory properties.
• Nucleoside Analog Synthesis: Serves as a precursor for modified nucleosides, which are important in the development of antiviral and anticancer therapeutics.
• Biochemical Research: Employed as a substrate or inhibitor in enzymatic studies related to purine metabolism and signaling pathways.
• Fine Chemical Production: Utilized in the custom synthesis of high-value, complex organic molecules for specialized applications.
• Academic & Institutional R&D: A valuable reagent for universities and research institutes conducting cutting-edge organic synthesis and drug discovery projects.

Basic Information

Product Name	9H-Imidazo[1,2-A]Purin-9-One, 3,5-Diacetyl-6,7-Bis(Acetyloxy)-3,5,6,7-Tetrahydro-
CAS No.	105528-80-1
Molecular Formula	C15H16N4O7
Molecular Weight	364.31 g/mol
Synonyms	3,5-Diacetyl-6,7-bis(acetyloxy)-3,5,6,7-tetrahydro-9H-imidazo[1,2-a]purin-9-one; 1,3-Diacetyl-6,7-diacetoxy-1,3,6,7-tetrahydroimidazo[1,2-a]purin-9(2H)-one; 6,7-Diacetoxy-1,3-diacetyl-1,3,6,7-tetrahydroimidazo[1,2-a]purin-9-one; Imidazo[1,2-a]purin-9-one, 3,5-diacetyl-6,7-bis(acetyloxy)-3,5,6,7-tetrahydro-; CAS 105528-80-1
EINECS	Contact for details

Quality Control

Our production of 9H-Imidazo[1,2-A]Purin-9-One, 3,5-Diacetyl-6,7-Bis(Acetyloxy)-3,5,6,7-Tetrahydro- adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. Certificates of Analysis (COA) detailing all specifications are provided to ensure traceability and compliance with your research or cGMP guidelines, as required.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials such as strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.